Bank Of America Corp Homology Medicines, Inc. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.53 - $1.14 $129,496 - $278,539	-244,333 Reduced 56.39%	188,971 $115,000
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.12 $8,063 - $10,880	9,715 Added 2.29%	433,304 $381,000
Q1 2023 May 12, 2023	BUY	$0.91 - $1.69 $56,390 - $104,725	61,968 Added 17.14%	423,589 $436,000
Q4 2022 Feb 10, 2023	BUY	$1.09 - $2.04 $16,859 - $31,552	15,467 Added 4.47%	361,621 $455,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $3.01 $98,087 - $190,478	63,282 Added 22.37%	346,154 $557,000
Q2 2022 Aug 12, 2022	BUY	$1.39 - $3.12 $274,094 - $615,232	197,190 Added 230.14%	282,872 $0
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $150,724 - $241,739	-57,971 Reduced 40.35%	85,682 $261,000
Q4 2021 Feb 08, 2022	SELL	$3.64 - $7.78 $112,770 - $241,032	-30,981 Reduced 17.74%	143,653 $523,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $551,621 - $799,438	91,784 Added 110.78%	174,634 $1.37 Million
Q2 2021 Sep 13, 2021	BUY	$6.02 - $9.64 $498,756 - $798,674	82,850 New	82,850 $603,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.